Mark Crossley

Executive Director, Chief Operating Officer & Chief Financial Officer at Indivior Plc

Mark Crossley

Mark Crossley

Executive Director, Chief Operating Officer & Chief Financial Officer at Indivior Plc

Biography

Mr. Mark Crossley is an Executive Director, Chief Operating Officer & CFO at Indivior PLC. He is on the Board of Directors at Indivior PLC. Mr. Crossley was previously employed as an Associate Director by Procter & Gamble Ltd. and a Global Finance Director by Reckitt Benckiser Pharmaceuticals, Inc. He received his undergraduate degree from Boston College, an undergraduate degree from US Coast Guard Academy and an MBA from Boston College.

Overview
Career Highlights

Indivior Plc

RelSci Relationships

137

Number of Boards

1

Relationships
RelSci Relationships are individuals Mark Crossley likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Director, Chief Executive Officer at Indivior Plc

Relationship likelihood: Strong

Governor at Millbank Academy

Relationship likelihood: Strong

Executive Director at Indivior Plc

Relationship likelihood: Strong

Chief Scientific Officer at Indivior Plc

Relationship likelihood: Strong

Former Chief of Staff at GlaxoSmithKline Plc

Relationship likelihood: Strong

Chairman at Sapience Therapeutics, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Executive Director at DBV Technologies

Relationship likelihood: Strong

Chief Legal Officer at Indivior Plc

Relationship likelihood: Strong

Chief Commercial & Strategy Officer at Indivior Plc

Relationship likelihood: Strong

Chief Human Resources Officer at Indivior Plc

Relationship likelihood: Strong

Paths to Mark Crossley
Potential Connections via
Relationship Science
You
Mark Crossley
Executive Director, Chief Operating Officer & Chief Financial Officer at Indivior Plc
Education

Boston College is one of the nation's best and most selective universities, with U.S. News & World Report ranking Boston College 31st among national universities, and Forbes ranking it 26th in its 2012 America's Best Colleges listing. Boston College confers more than 4,000 degrees annually in more than 50 fields of study through eight schools and colleges. Faculty members are committed to both teaching and research having earned nearly $60 million in research grants in the last year alone. The University has made a major commitment to academic excellence. As part of its Strategic Plan, Boston College is in the process of adding 100 new faculty positions, expanding faculty and graduate research, increasing student financial aid to more than $128 million annually, and widening opportunities in key undergraduate programs, such as international study, internships and student formation. Boston College has experienced tremendous growth in recent years, including a 75 percent increase in undergraduate applications over the past decade, to more than 34,000 for the 2,250 seats in its freshman class. During the same period, an increase in voluntary giving from alumni has helped to move the University's endowment to approximately $1.9 billion. Boston College students have also earned more than 200 prestigious academic scholarships over the past decade, including 2 Rhodes Scholarships, 4 Marshalls, 9 Goldwaters and 162 Fulbright grants.

United States Coast Guard Academy is one of the smallest of the five U.S. federal military academies.

Career History
Executive Director, Chief Operating Officer & Chief Financial Officer
2012 - Current

Indivior PLC is a holding company, which engages in the manufacture and distribution of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, Subutex Tablet, and Sublocade Injection. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

Associate Director
Prior

Procter & Gamble Ltd. manufactures and markets consumer products. It provides fabric and home care products which include laundry, cleaning, detergents, soaps, softeners, and cleansers. The company was founded in 1837 and is located in Newcastle, UK.

Global Finance Director
Prior

Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA.

Boards & Committees
Executive Director, Chief Financial Officer
2012 - Current

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, Subutex Tablet, and Sublocade Injection. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mark Crossley. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mark Crossley's profile does not indicate a business or promotional relationship of any kind between RelSci and Mark Crossley.